The combination of anti‑HBc and anti‑HBs levels is a useful predictor of the development of chemotherapy‑induced reactivation in lymphoma patients with resolved HBV infection

Tokuhiro Matsubara(Toyonaka Municipal Hospital), Masami Inada(Kyoto University), Kaori Mukai(Toyonaka Municipal Hospital), Tsutomu Nishida(Toyonaka Municipal Hospital), Masashi Yamamoto, Aya Sugimoto(Toyonaka Municipal Hospital), Shiro Hayashi(Toyonaka Municipal Hospital), Akiyoshi Shimoda(Osaka Gakuin University), Takahiro Amano(Japanese Foundation For Cancer Research), Kei Takahashi(Howard Hughes Medical Institute), Koji Fukui(Shibaura Institute of Technology), Sachiko Nakajima(Toyonaka Municipal Hospital), Hiromi Shimakoshi(Toyonaka Municipal Hospital)
Oncology Letters
September 21, 2017
Cited by 32


Related Papers